EMA — authorised 24 June 2022
- Application: EMEA/H/C/006019
- Marketing authorisation holder: Valneva Austria GmbH
- Local brand name: COVID-19 Vaccine (inactivated, adjuvanted) Valneva
- Indication: COVID-19 Vaccine (inactivated, adjuvanted) Valneva is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 to 50 years of age. The use of this vaccine should be in accordance with official recommendations.
- Status: withdrawn